Benjamin David Novak

Ben is an active member of the startup and venture capital community.  He serves on multiple Boards and Advisory Boards.  Additionally, he routinely speaks at events, conferences, and universities on a variety of topics related to technology, entrepreneurship, and investing.

Outside of his role at Morgan Lewis, Ben is personally an active angel investor, who invests primarily in East Coast based seed stage technology companies. Prior to joining Morgan Lewis, Ben was an associate in the venture capital and technology practice of a prominent national law firm.

Financings

• Flowonix Medical, a medical device manufacturer, in its $33 million Series B preferred stock financing
• Upskill, formerly APX Labs, an augmented reality technology company, in its Convertible Debt financing led by New Enterprise Associates
• 101 Edu, an edtech software company, in its Series Seed Preferred Stock financing
• Medcura, a clinical-stage life sciences company, in its Series Seed Preferred Stock financing
• Untethered Labs, a cybersecurity hardware and software company, in its Series A Preferred Stock financing
• Gridless Power, a cleantech hardware and software company, in its Series A-1 Preferred Stock financing
• Videolicious, a video software company, in its Series E Preferred Stock financing
• Inbox Health, a digitalhealth software company, in its Series Seed Preferred Stock financing
• Flowonix Medical, a medical device manufacturer, in its Series BB financing
• Theaprin Pharmaceuticals, a specialty pharmaceutical company, in its Common Stock financing
• SeventySix Capital in its investment in Vegas Stats & Information Network, a sports betting media network providing news, analysis, and proprietary data

Mergers & Acquisitions

• Aristech Surfaces, a producer of continuous cast acrylic sheets for the wellness, architectural, transportation, and industrial markets, in its $445 million sale to Trinseo
• Corente, a software technology company, in its sale to Oracle
• General Econopak, a manufacturer of sterility maintenance, barrier protection, and sterile cleanroom products, in its $175 million sale to Steris Corporation
• SK Capital Partners in its acquisition of Tri-Tex, a global chemical company
• A&E Medical, a medical device company, in its sale to Vance Street Capital
• Richard Forman, the sole stockholder of Forman Mills, a retail chain and department store, in the sale of the company to Goode Partners
• SK Capital Partners in the sale of its portfolio company, Calabrian, a producer of liquid sulfur dioxide, to INEOS Enterprises